2002
DOI: 10.1093/jnen/61.2.111
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Nicotinamide N-Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian Brain

Abstract: Nicotinamide N-methyltransferase (NNMT) has been proposed as a link between the environmental and genetic factors of Parkinson disease (PD). Therefore, we explored the hypothesis that high levels of NNMT expression may predispose to the development of PD. Regions of high mRNA expression were shown in the spinal cord, medulla, and temporal lobe, with lowest expression in the cerebellum, subthalamic nucleus, and caudate nucleus. Using 2 NNMT antibodies, the protein was shown to be expressed in multipolar neurons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
104
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 80 publications
(108 citation statements)
references
References 38 publications
4
104
0
Order By: Relevance
“…Urinary excretion of MNA is increased and excretion of pyridone, its catabolic product, is reduced in PD patients [16] . PD patients show higher levels of NNMT activity and protein in brain tissue than controls [17] . MNA destroys several subunits of cerebral complex I, particularly 30-kDa protein [18] , and MNA injection into the rat substantia nigra pars compacta significantly decreases the dopamine content in the striatum [19] .…”
Section: Introductionmentioning
confidence: 83%
“…Urinary excretion of MNA is increased and excretion of pyridone, its catabolic product, is reduced in PD patients [16] . PD patients show higher levels of NNMT activity and protein in brain tissue than controls [17] . MNA destroys several subunits of cerebral complex I, particularly 30-kDa protein [18] , and MNA injection into the rat substantia nigra pars compacta significantly decreases the dopamine content in the striatum [19] .…”
Section: Introductionmentioning
confidence: 83%
“…NNMT was first identified by cDNA cloning from the liver and the protein is predicted to be present in the cytosol (Aksoy et al, 1995). Several diseases are associated with abnormal nicotinamide metabolism resulting in the production of elevated levels of N-methylnicotinamide; these include Parkinson's disease and hepatic cirrhosis (Cuomo et al, 1994;Parsons et al, 2002). Recently, NNMT was reported as novel serum markers of human colorectal cancer as potential candidates for noninvasive detection of early colorectal neoplasm (Roessler et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…First, there was an abundance of available post mortem tissue from PD cases, compared to regions more substantially affected by PD, such as the substantia nigra. Second, dopaminergic neuronal transmission occurs in the cerebellum, including dopaminergic input from the substantia nigra, while remaining largely unaffected by PD pathology and neuronal degeneration (Hurley et al, 2003;Parsons et al, 2002). We also genotyped the aforementioned SNPs using DNA extracted from the brain tissue and assessed whether any SNP had an effect on the expression of SPR.…”
Section: Introductionmentioning
confidence: 99%